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In 1985 we isolated a new vascular anticoagulant 
protein VACa, now called annexin V, with a high  bind- 
ing  affinity (& < 10”’ M) for phospholipids. Its anti- 
coagulant  effect  was  attributed  to displacement of co- 
agulation factors from the phospholipid membrane. 
The present  study  demonstrates that  the inhibition of 
prothrombinase activity by annexin V strongly de- 
pends on the  curvature of the  membrane  surface  and 
on  the calcium concentration.  Half-maximal  inhibition 
of prothrombinase  on  and  binding of annexin V to small 
vesicles, composed of 20% phosphatidylserine  and 80% 
phosphatidylcholine, requires 2-3 mM calcium. With 
large vesicles and planar bilayers considerably less 
calcium is required  for  inhibition of prothrombinase 
and for  lipid  binding.  Half-maximal  binding of annexin 
V to  large vesicles and  to  planar  bilayers  occurs at 0.7 
and 0.2 mM calcium,  respectively. This seemingly con- 
firms the displacement model. The displacement of 
coagulation  factors,  however,  proved to be  incomplete, 
with  residual  surface  concentrations of factors Xa, Va, 
and prothrombin  sufficient  for  effective  production of 
thrombin.  Cryoelectron microscopy revealed that  an- 
nexin V binding to  large vesicles  caused planar  facets, 
indicating  the  formation of large  sheets of clustered 
annexin V. Apparently,  the  formation of these two- 
dimensional arrays is promoted by calcium and ham- 
pered by high surface  curvature.  It is speculated that 
the complete inhibition (>99%) of prothrombinase  ac- 
tivity by annexin V is caused by the reduced lateral 
mobility of prothrombin  and  factor Xa in  rigid  sheets 
of annexin V covering  the membrane. 
Several steps  in the complicated process of blood coagula- 
tion, for instance the activation of factor  X by the factor IXa/ 
factor VIIIa complex or the conversion of prothrombin  (factor 
11) to thrombin  (factor IIa) by the factor Xa/factor Va (pro- 
thrombinase) complex, are greatly stimulated by the adsorp- 
tion of both the enzyme/cofactor complex and  the  substrate 
to phospholipid membranes. For instance, the thrombin-gen- 
erating capacity of factor  Xa is enhanced by four to six orders 
of magnitude after its assembly with factor Va on a lipid 
surface (see Ref. 1 for a review). 
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Annexin V (formerly called vascular anticoagulant a (2)) 
has a high calcium-dependent binding affinity for negatively 
charged phospholipids (3-5) and blood platelets (6) .  The 
protein was discovered by its anticoagulant effect (2). Since 
then  it  has been demonstrated to inhibit several phospholipid- 
dependent  reactions, such as lipid degradation by phospholi- 
pase Az (7,8), production of thrombin by the prothrombinase 
complex (2, 9-11), and activation of factor X by the tissue 
factor/factor VIIa complex (12-15). Annexin V does not in- 
hibit  factor  Xa  activity  in the absence of phospholipids and 
does not bind to factor Xa (11). It also has no proteolytic 
activity (2). Therefore, it is generally assumed that annexin 
V inhibits blood coagulation by displacement of blood coagu- 
lation  factors from the procoagulant phospholipid surface. 
In the present study it is observed that, for low (3 mM) 
calcium concentrations, the inhibition of prothrombinase ac- 
tivity by annexin V is considerably less for small unilamellar 
vesicles (SUV)’ than for large vesicles (LV), platelets, or 
planar bilayers. It is verified that indeed less annexin V binds 
to SUV than to planar bilayers. These findings seem to 
confirm the displacement concept, but a separate series of 
experiments  demonstrates that displacement of coagulation 
factors from the phospholipid surface by annexin  V is incom- 
plete. The remaining surface concentrations of factor Xa, 
factor Va, and prothrombin are sufficient for effective pro- 
duction of thrombin. Annexin V thus seems to interfere with 
the conversion process itself. Using cryoelectron microscopy 
it was found that adsorption of annexin  V  on large phospho- 
lipid vesicles, with a low surface curvature, results in the 
formation of facets on the vesicles. Apparently, sheets of 
clustered  annexin V molecules are formed on the surface, with 
sufficient rigidity to deform the bilayer. It is suggested that 
these  clusters may provide a fencing mechanism, interfering 
with the lateral transport of prothrombin  on the membrane 
toward the prothrombinase complex. 
MATERIALS AND METHODS 
Phospholipids-1,2-Dioleoyl-sn-glycero-3-phosphatidylcholine 
(PC) was purchased from Sigma Chemical Co. 1,2-dioleoyl-sn-glyc- 
ero-3-phosphatidylserine (PS) was bought from Avanti Polar Lipids. 
Unless stated otherwise  a  mixture of 20% PS/80%  PC  (PS/PC) was 
used. Small unilamellar vesicles (20-30 nm diameter, SUV) were 
prepared by sonication of a  nitrogen-dried phospholipid mixture in 
buffer (16). Large vesicles (70-200 nm  diameter, LV) were obtained 
by lipid extrusion  through  a 200-nm polycarbonate  filter  under mod- 
erate nitrogen  pressure (17).  Planar phospholipid bilayers were 
stacked on hydrophylic silicon slides (Wacker Chemie) by dipping 
the slides in a  stirred-vesicles  solution as described (18). 
The abbreviations used are: SUV,  small  unilamellar vesicles; LV, 
large vesicles; PC, 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine; PS, 
1,2-dioleoyl-sn-glycero-3-phosphatidylserine; PG, phosphatidylgly- 
cerol; Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid. 
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17908 Clustering of Lipid-bound  Annexin  and  ItsA ticoagulation  Effect 
Buffers-All experiments were performed at room temperature 
(20-22  'C) in a Tris-HC1 buffer, pH 7.5, unless platelets were  used. 
The Tris-HC1 buffer, unless stated otherwise, contained 50 mM Tris, 
100 mM NaC1, 3 mM Ca2+, and 0.5 g/liter bovine serum albumin 
(Sigma, A-7030 fatty acid free) to prevent protein depletion by 
adsorption to cuvette walls, stirrer etc. Experiments with platelets 
were performed in Hepes buffer, pH 7.4, containing 3 mM Caz+, 137 
mM NaC1,  2.7 mM KC1, 1.7 mM MgCl,, 10 mM Hepes, 25 mM glucose, 
and 0.5 g/liter bovine serum albumin. 
Proteins-Human recombinant annexin V, prepared as described 
in Ref. 13, was a kind gift of Boehringer Ingelheim. Coagulation 
factors 11, X, and  V were purified from bovine plasma according to 
Lindhout  (19). Factors X and V were activated with Russels Viper 
Venom-X (Sigma) (20) and thrombin  (19), respectively. Concentra- 
tions of factor Xa preparations were determined by active-site titra- 
tion with p-nitrophenyl-p'-guanidinobenzoate hydrochloride (ICN 
Nutritional Biochemicals). Low factor Xa concentrations were deter- 
mined with a prothrombinase assay with excess factor Va (1 nM), 
20% PS/80% PC vesicles (50 p ~ ) ,  and prothrombin (1 p ~ ) .  Standard 
curves from 0.1 to 1 PM factor Xa yielded kat values of 3850 f 350 
min" (mean & S.D.) at 37 "C. Prothrombin was incubated for a t  least 
10 min with the indicated calcium concentration at 20 "C before the 
start of the experiment. Prothrombin  concentrations were determined 
after activation with Echis carinata venom (Sigma). Prothrombinase 
activity was determined in serial samples quenched with 20 mM 
EDTA and 0.1 g/liter soybean trypsin  inhibitor (Sigma). The cups 
were stored on ice until thrombin concentrations were determined 
with the chromogenic substrate S-2238 (Kabi), using a Cobas Bio 
spectrophotometer (Hoffmann-La Roche) at 37 "C (18). Factor Va 
concentrations were determined by assessment of prothrombinase 
activity with excess factor Xa (100 pM), vesicles (50 pM) ,  and pro- 
thrombin (1 p ~ )  at 37 "C. 
Measurement of Protein Adsorption on Planar Bilayers-Binding 
of proteins to planar phospholipid bilayers was measured by ellipso- 
metry (5, 21). Experiments were performed in a  quartz cuvette filled 
with 5 ml  of buffer and rendered hydrophobic by pretreatment with 
Sigmacote (Sigma SL-2). The solution was stirred with a Teflon- 
coated magnetic stirrer (length, 8 mm; diameter, 2 mm),  rotating at 
1800 rpm and separated 1-2 mm from the site of measurement on 
the slide. 
Measurement of the Adsorption of Annexin V on Vesicle-The 
initial adsorption rate of annexin V on planar PS/PC bilayers is 
transport-limited  and satisfies the relation: dI'/dt = c b u l k . A ,  with r 
representing the surface concentration of protein (pg.cm-'), Cbulk 
representing the bulk concentration of protein ( p g . ~ m - ~ ) ,  and A 
representing the mass transfer  constant  (cm-s"), which depends on 
stirring conditions, the buffer viscosity, and  the diffusion coefficient 
of the protein (5, 22). Experimentally this was verified for annexin  V 
concentrations from 3 to 100 nM. These observations are used to 
estimate the annexin  V binding to  PS/PC vesicles through measure- 
ment of the reduction of the free annexin  V  concentration caused by 
binding to the lipid vesicles. This is illustrated in Fig. 1: without 
addition of lipid vesicles the adsorption rate is constant up to 75% of 
maximal surface coverage Addition of 1 pM PS/PC vesicles 1 
min after  the start of the adsorption results in a rapid decrease of the 
0 5 10 15 
time (min) 
FIG. 1. Ellipsometric measurement of annexin V binding to 
vesicles. At t = 0 annexin V (15 nM) was added to  the cuvette (0) 
and annexin V adsorption to a PS/PC bilayer was measured. After 1 
min PS/PC SUV (1 p ~ )  was added (O), and  this resulted within 15 
s after addition in a decrease of the adsorption rate from 8.5 X 
pg. cm-'. s-l before  vesicle addition to 2.8 X 10" pg. cm-'.  s-'. Straight 
lines represent the best-fitting regression line to  the annexin adsorp- 
tion up to 1 min and  the annexin adsorption 1 min after addition of 
the tesicles. The experiment was performed at room temperature 
(20-22 "C) in Tris-HC1 buffer (pH 7.5,50 mM Tris, 100 mM NaCl, 10 
mM CaCl,, and 0.5 g/liter bovine serum albumin). 
adsorption rate  to about 30% of the initial adsorption rate. For an 
annexin v concentration of 15 nM and 1 pM Ps/Pc  SUV the transient 
is completed within 10-15 s. Thereafter,  a new, lower, steady state 
adsorption rate is established, corresponding to  the new free annexin 
V concentration. Addition of excess lipid vesicles (10 p~ PS/PC)  to 
15 nM annexin  V at 3 mM Ca" completely stops the adsorption. From 
these data it is concluded that the steady-state free annexin V 
concentration is rapidly established and  that  the quasi-steady-state 
adsorption rate observed after addition of vesicles is proportional to 
the free annexin  V  concentration. It is unaffected by lipid vesicles 
per se or by lipid-bound annexin V. In the binding experiments 
(presented  in Fig. 3) the vesicles  were added to  the cuvette prior to 
the addition of annexin V, and  the free annexin V concentration was 
determined using the calibration line mentioned before. Best accuracy 
is attained if binding to vesicles causes a reduction of the free annexin 
V concentration exceeding 25%. For experiments with 15 nM annexin 
V this required 1 p~ SUV and 2 pM LV. Experiments with 100 nM 
annexin V were performed with 5 p~ SUV. 
Measurement of Prothrombinase Activity  on  Blood Platelets- 
Washed platelets were prepared as described (23). Stirred  platelets 
(1.2 X lo6 platelets per ml = 0.1 p~ phospholipid) were activated by 
incubation with 10 p~ calcium ionophore A-23187 (Sigma) for 10 
min. Since platelets  contain factor V, a factor Xa-limited assay was 
used. Factor Va (1 nM) and factor Xa (10 PM) were  allowed to bind 
for 5 min. Annexin V was added and after  2 min the reaction was 
started by addition of a  final  concentration of 1 p~ prothrombin. 
Visualization of Vesicles-Vesicles  were visualized with the use of 
cryoelectron microscopy (24). No stains were  used. A 700-mesh grid 
of 3.5-pm thickness was dipped into the vesicle suspension (PS/PC 
concentration, 5 mM). The adhering film  was vitrified by rapid 
plunging into liquid ethane. Films were stored in liquid nitrogen and 
observed in a  Gatan 626 cryoholder at -170  "C with a  Philips CM12 
microscope. Electron micrographs were taken at 100 kV under low 
dose conditions, and 1-2-pm defocus was  used to improve contrast. 
RESULTS 
Fig. 2 presents  the inhibition of prothrombinase activity on 
SUV (0.1 p~ PS/PC), LV (0.1 p~ PS/PC),  planar bilayers 
(0.6 cm2 in  5 ml  of -0.06 p~ PS/PC)  and platelets (1.2 x lo6 
ml-'  of  -0.1 p~ phospholipid) at  a calcium concentration of 
3 mM as function of the  annexin V  concentration.  Without 
addition of annexin the prothrombinase activities, expressed 
as moles of thrombin produced per mol  of factor Va (Xa for 
platelets)  per min were  1900, on SUV, 1400 on LV, 2200 on 
planar bilayers, and 1200 on platelets. Complete inhibition, 
with a half-maximal annexin V  concentration of 4-5 nM, is 
observed for platelets and  planar bilayers. Inhibition  on SUV 
is incomplete with a maximal inhibition of only 40%, while 
annexin V (nM) 
FIG. 2. Inhibition of prothrombinase. Inhibition of prothrom- 
binase activity on planar bilayers (0), on activated platelets (A), and 
on small (0) and large vesicles (A). Lipid concentrations were 0.06- 
0.1 p ~ .  Prothrombinase activity was produced as follows. On planar 
bilayers 2 fmol/cmz prothrombinase was assembled by adsorption of 
10 PM Va and 50 p~ factor Xa during 7 min (18). The assembly  was 
stopped by replacement of the buffer. Calcium ionophore-activated 
platelets were incubated during 5 min with 10 PM factor Xa and 1 
nM factor Va.  Vesicles  were incubated during 5 min with 10 pM factor 
Va and 100 PM factor Xa. After assembly of prothrombinase annexin 
V was added to  the final concentration indicated on the horizontal 
axis, and after 5-10 min prothrombin was added to  start thrombin 
production. Calcium concentration was 3 mM, and  the experiments 
were performed at room temperature. 
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Clustering of Lipid-bound  Annexin  and  Its  Anticoagulation  Effect 
for LV an intermediate  inhibition of 90% is observed. Deple- 
tion of annexin V, due to lipid binding, plays only a minor 
role because 0.1 p~ vesicles or planar bilayers could maximally 
bind 1.2 nM annexin  V (see below). The horizontal axis in Fig. 
2 therefore represents, apart for this minor correction, the 
free  annexin  V  concentration. 
The disparity between prothrombinase inhibition on low 
curvature  (planar bilayers and platelets) and high curvature 
(SUV) lipid is investigated further in Fig. 3 by comparison of 
prothrombinase  inhibition by annexin V and lipid binding of 
annexin V as a  function of the calcium concentration. The 
left panel shows that prothrombinase inhibition increases 
with increasing Ca2+  concentration and decreases with surface 
curvature. Ultimately, at  10 mM calcium, even for SUV com- 
plete  inhibition of prothrombinase is observed. Measurement 
of prothrombinase  activity was restricted to calcium concen- 
trations above 1 mM as  the prothrombinase complex tends  to 
dissociate below this concentration. The right  panel of Fig. 3 
shows the parallel effect of calcium on lipid binding of annexin 
V. Binding at 10 mM Ca'+ was 12 mmol of annexin V/mol 
PS/PC for planar bilayers and SUV and 6 mmol of annexin 
V/mol PS/PC for LV. The half-maximal calcium concentra- 
tion for inhibition as well as binding was 2-3 mM on SUV 
and 0.7 mM on LV.  At 1 mM calcium prothrombinase  inhibi- 
tion on planar bilayers is still nearly complete (87%), and 
half-maximal binding on planar bilayers required only 0.2 mM 
calcium. Frequent lipid inclusions as observed for LV (see 
Fig. 7). caused a lower annexin V binding at  10 mM Ca2+ (5.5- 
6.3 mmol of annexin V/mol PS/PC). Therefore, titrations 
were performed with 2 p~ LV instead of 1 p~ SUV. 
Fig. 4  demonstrates that  annexin V is unable to completely 
displace factor Va from the phospholipid surface. In the 
control situation, with 2 fmol-cm-' of factor Va adsorbed on 
the surface and 50 PM factor Xa in solution, a thrombin 
production of  4.4 f 0.7 pmol. cm-' was observed after addition 
of 1 p~ prothrombin. Complete coverage of the  PS/PC bilayer 
with  annexin  V reduced the  thrombin production to only 6% 
of the original conversion rate. As annexin V was removed 
from the buffer prior to the measurement of prothrombin 
conversion this demonstrates that surface-bound annexin V 
interferes with the conversion process. Thrombin generation 
after removal of annexin  V from the surface and reconstitu- 
tion of prothrombinase by addition of 50 PM factor  Xa  7 min 
prior  to prothrombin  addition  amounted to 3.0 pmol .cm-'. 
Thus 68% of the original factor Va adsorbed to  the surface 
was  retained after displacement by annexin V. 
Fig. 5 shows that annexin  V does not completely displace 
Factor  Xa from the surface. About 20 fmol . cm-'  of factor Xa 
was adsorbed on  a planar bilayer during  incubation  with 50 
pM factor  Xa for 14 min. The cuvette was flushed to remove 
+--"TO 0 5 10 
Ca*+ (mM) Ca" (mM) 
FIG. 3. Effect of calcium on inhibition of prothrombinase 
activity by annexin V and on binding of annexin  V to PS/PC 
membranes. Left panel shows the  extent of inhibition of prothrom- 
binase  on planar bilayers (O), SUV (O), and LV (A) by 1 p~ annexin 
V as function of the calcium concentration.  Experiments were per- 
formed  under  conditions as described in Fig. 2. Rzght panel shows the 
PS/PC binding of 100 nM annexin V to  planar bilayers (0) and of 15 
nM annexin v to 1 p M  suv (0) and 2 p M  L v  (A). 
17909 
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FIG. 4. Incomplete displacement of factor Va from the PS/ 
PC membrane. Prothrombinase was assembled on the  PS/PC bi- 
layer as described in Fig. 2. Thrombin production after addition of 1 
PM prothrombin  is shown in the control situation (O), after complete 
coverage of the lipid surface with annexin V (A), and when annexin 
V was removed after complete surface coverage (0). Complete surface 
coverage with annexin V was attained by adsorption of 100 nM 
annexin V  during  5 min. This was followed by flushing with 50 ml  of 
buffer containing 3 mM Ca2+ in order to remove annexin V from the 
buffer. Prior  to addition of prothrombin the bilayer was incubated 
for 7 min with 50 PM factor Xa. Annexin V was removed from the 
PS/PC surface by flushing the cuvette  with buffer containing only 
50 p M  Ca", and  thrombin production was measured  after  reconsti- 
tution of prothrombinase by incubation for 7 min with 3 mM calcium 
and 50 PM factor Xa prior to prothrombin  addition. 
N 4  - 51 
v 
X " l  
0 
0 10 20 
time (min) 
FIG. 5. Incomplete displacement of factor Xa from the PS/ 
PC membrane. About 20 fmol/cm2 of factor Xa was adsorbed to  a 
planar  PS/PC bilayer. A  mask,  preventing  exposure to  air, was placed 
on the lipid membrane, and the slide was transferred to a clean 
cuvette. The release of factor  Xa from the bilayer was measured by 
determination of the factor Xa concentration in serial  samples from 
the buffer. After measurement of spontaneous release of factor  Xa 
during 10 min 100 nM annexin V was added, and factor Xa release 
was followed for another 10 min. Finally, 3.5 mM EDTA was added 
in order to quantify the remaining membrane-bound factor Xa. 
Experiments on PS/PC (0) and pure PC (0) bilayers are shown. 
free factor Xa and allowed to equilibrate for 7 min. During 
this period part of the factor Xa desorbs from the lipid surface. 
Regrettably, the accuracy of ellipsometry is insufficient to 
monitor these minute adsorbed quantities (-1 ng/cm'), but 
for a higher surface coverage of  0.044  pg/cm' (<lo% of I?,,) 
a value for the desorption rate  constant, k,, = 0.15-0.3  min" 
is observed. A mask was placed over the phospholipid mem- 
brane, preventing exposure to  air,  and  the slide was trans- 
ferred to a clean cuvette with buffer. This precaution is needed 
to prevent nonspecific release of factor Xa from the cuvette 
walls. As shown in Fig. 5, some factor Xa slowly desorbs 
spontaneously from the surface. Annexin V was added but 
hardly stimulated  factor Xa release. Addition of EDTA, how- 
ever, released 2.7 fmol.cm-* of factor Xa from the bilayer, 
and  this  quantity exceeds the surface concentration of factor 
Va used in the previous experiments. Thus  the  total release 
after  transfer  to  the clean cuvette amounts  to only 4.7 fmol/ 
cm', i.e. 20-25% of the 20 fmol/cm' initially adsorbed. This 
discrepancy is, however, only apparent due to neglect of factor 
Xa desorption during the 7-min equilibration, which amounts 
to 60-80% of the initially adsorbed quantity. A phospholipid 
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17910 Clustering of Lipid-bound  Annexin  and Its Anticoagulation  Effect 
bilayer of 100% PC did not show factor  Xa release,  excluding 
nonspecific  effects. 
Binding of prothrombin  to a  phospholipid membrane fully 
covered  with annexin V is  demonstrated  in Fig. 6. Annexin V 
was adsorbed to its maximal coverage of 200 ng.cm-' (5.7 
pmol. cm"), and  prothrombin was added to a final  concentra- 
tion of 1 p ~ .  After  2 min,  the  extra  adsorption of prothrombin 
was 29 & 3.2 ng.cm-2 (0.4 pmol.cm-*). As discussed below, 
this surface concentration largely exceeds the  concentration 
required for  efficient thrombin  production.  For buffer concen- 
trations in the micromolar range,  similar effects as shown  in 
Fig. 6 can be  shown  for factor  Xa  and  factor Va. However,  for 
picomolar factor  Xa  and Va concentrations,  used  in  the as- 
sessment of prothrombinase activities, the adsorptions are 
correspondingly smaller  and  cannot be detected by ellipso- 
metry. 
Fig. 7 shows that annexin V forms sheets of clustered 
protein  on surfaces  with low curvature.  The vesicles assumed 
bizarre,  sharply edged shapes like  rods,  cubes, pyramids,  etc. 
Some of the rods were straight  up  to 300 nm,  with a deviation 
of less than 3 nm. Although the control vesicles contained 
occasional bulges or were bilamellar, they never displayed 
these  straight sides. Vesicles in  the  presence of human  serum 
albumin were not  different  from  control vesicles. 
DISCUSSION 
Ellipsometric Determination of Annexin V Binding to  Ves- 
icles-As explained in Fig. 1 the  measurement of annexin V 
binding  to vesicles consists of the  determination of the free 
annexin V concentration in a suspension of vesicles. This 
" O f + , , .  anncxin V 
0 2 4 6 
time (min) 
FIG. 6. Prothrombin adsorption to a PS/PC bilayer covered 
with annexin V. Adsorption of annexin V (100 nM) to a PS/PC 
hilayer was allowed t o  proceed until r,,, was reached.  About 1.5 min 
thereafter 1 WM prothrombin was added, and  the  additional  adsorption 
o f  a t  least 30 ng/cm2  was  observed.  Calcium concentration was 3 mM. 
FIG. 7. Visualization of shape changes induced by annexin 
V binding to large vesicles. Samples of large vesicles, 70-200-nm 
diameter,  and  PS/PC  concentration of 5 mM, were rapidly  vitrified 
in liquid ethane, and electron micrographs were taken a t  -170 "C. 
The left panel shows vesicles without  annexin V, and  the right panel 
shows vesicles incubated for 10 min a t  20 "C  with 200 PM annexin V. 
Buffer contained 3 mM calcium. Bar indicates 100 nm. 
concentration of free protein is determined by ellipsometry 
from the  initial  transport-limited  adsorption  rate  to a PS/PC 
bilayer, which was calibrated by performing control experi- 
ments without added vesicles. This technique requires that 
the  redistribution of annexin V  between solution  and vesicles 
is rapid compared to the duration of the initial phase of 
adsorption  to  the  planar bilayer. This was demonstrated in 
Fig. 1 for 1 p M  Ps/Pc SUV and 15 nM annexin v. 
Incomplete Inhibition of Prothrombinase on Small Vesi- 
cles-As was shown in Fig. 2, inhibition of prothrombinase 
by annexin V  was  incomplete on small  phospholipid vesicles. 
This  contrasts  with  results  reported by other  authors (2, 7, 
10, ll),  but  in  these  studies higher calcium concentrations (5- 
10 mM) were used and vesicle size was not given. The poor 
inhibition of prothrombinase  on  SUV is correlated  to a high 
calcium requirement for the  binding of annexin V to  these 
surfaces (Fig. 3). It  seems  as if the rigid clusters, shown in 
Fig. 7, are more  difficult to form on highly curved  surfaces. 
Calcium Requirement of Annexin  V  Binding-The calcium 
concentration required  for binding of annexin V is a  function 
of the  membrane  content of anionic phospholipid such  as PS 
(5). The PS in  small vesicles may be preferentially located  in 
the  inner  membrane l aflet, and  this could explain the reduced 
binding of annexin V. However, for sonicated vesicles it  has 
been estimated  that PS concentration  in  the  outer leaflet was 
only 30% reduced compared to a symmetrical distribution 
(25). This implies that in the SUV preparations used  in this 
study  the  amount of PS in  the  outer leaflet would be about 
13%. However,  only  a PS content below 5% could explain the 
increased calcium requirement  (5).  Furthermore, symmetrical 
distribution,  or even preferential  accumulation of phosphati- 
dylglycerol (PG) in the  outer leaflet, has been reported (26- 
29). Taking  sonicated vesicles instead of planar bilayers, we 
found a similar  shift  in  the calcium concentration required 
for half-maximal binding of annexin V to PG/PC vesicles 
(From 0.15 mM for 20% PG/80%  PC  planar bilayers to 4.4 
mM for 20% PG/80%  PC vesicles. Results  not  shown).  It is 
concluded that asymmetrical distribution of lipids in the 
bilayer cannot explain the observed  effects, and  that surface 
curvature is probably  more important. 
Reduced binding of annexin V on  SUV  and LV could be 
caused by a lower binding affinity, a reduced number of 
binding  sites,  or  both.  For  SUV we checked the effect of the 
free annexin V concentration  on  the binding to vesicles and 
observed that increasing the free annexin V concentration 
from 9 to 70 nM hardly affected the  binding  (data  not  shown). 
Thus  the decreased binding reflects  a  decrease  in the number 
of binding sites. This is consistent with the high binding 
affinity (& < 0.1 nM) reported for vesicles at  1.2 mM Ca" 
(4), a  value  two to  three  orders below the  concentrations used 
in Fig. 3. The  maximal surface coverage of 2 mmol of annexin 
V per mol of lipid, reported  in  the  same  study (4), is close to 
the value of  2.2 found  in the  present  study for 1 mM calcium 
(c.f. Fig. 3). 
Displacement of Adsorbed Coagulation Factors by Annexin 
V-Annexin V is  able  to displace >90% of maximal  surface 
coverage of the coagulation factors  Xa, Va, and 11. However, 
Figs. 4-6 show that  the  remaining  amounts of adsorbed co- 
agulation factors are sufficient for effective production of 
thrombin. For prothrombin this result is confirmed by the 
observation  that  prothrombin  is  able  to compete for annexin 
V binding (4). The residual binding of more than 400 fmol. 
cm-', is 10 times lower than  the maximal  binding of prothrom- 
bin of 3500 fmol.crn-' (30),  but for the low prothrombinase 
activity  on  the surface it was estimated  that a  surface  concen- 
tration of only 2 fmol -cm-* of prothrombin is required for 
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maximal  production of thrombin (18). Similarly  it was cal- 
culated that assembly of prothrombinase is already half- 
maximal for  a surface  concentration of 0.44 fmol.cm2  factor 
Xa, which is 5-6-fold below the  quantity of factor  Xa  retained 
after  displacement by annexin V (c.f. Fig. 5). I t  is concluded 
that  the  anticoagulant effect of annexin V cannot be explained 
by  displacement of coagulation factors  from  the lipid  surface. 
Formation of Ordered  Clusters of Annexin V-As demon- 
strated  in Fig. 7 the cryoelectron micrographs revealed mul- 
tifaceted phospholipid structures with sharp edges. These 
shape  changes  can only  be explained by assuming  that large 
clusters of annexin V induce  surface  deformation. Mosser et 
al. (31) have  shown that  annexin V binds  on  planar  phospho- 
lipid  monolayers in a  two-dimensional array of repeated  tri- 
mers. Their  data could not  confirm  or reject the  hypothesis 
that  the  clusters  extend  to include  more than  three  protein 
molecules. The  straight  facets observed in  the  present  study 
appeared  to be limited by the size of the vesicles and some- 
times  measured more than 100 x 100 nm.  This involves up  to 
400 molecules of annexin V, as can be calculated from the 
mean  area  per  annexin V molecule (5,  31). No changes  in  the 
shape of small  sonicated vesicles in  the  presence of annexin 
V were observed, even at 10 mM calcium (data  not  shown). 
This may be due to  the defocus of the objective lens (0.5-2 
pm) required for sufficient contrast.  Using  such defocus  facil- 
itates  the recognition of straight  facets  but  also  results  in a 
blurring of the image,  which  may  obscure the high  resolution 
information required to  detect  facets  on  small vesicles. How- 
ever, if the vesicle diameter of 20-30 nm of SUV  is  compared 
to  the average diameter of an annexin V molecule (5  nm), 
only 50-100 molecules of annexin V would fit  onto  one vesicle 
and  the  plane of adsorption of each  annexin would make  an 
angle of 10-20" with the planes of its neighbors. On large 
vesicles, the molecules adsorb in extended planes with an 
average  angle  between  neighboring  molecules of less than 1". 
It is therefore likely that  steric  constraints  counteract clus- 
tering of annexin V molecules on highly  curved  bilayers and 
this may cause  the higher  calcium requirement for annexin V 
binding observed in Fig. 3. 
Inhibition of Membrane-bound  Transport of Prothrombin- 
The  data  presented  in Figs. 2-4 show that  prothrombinase 
activity  on  PS/PC  membranes  can be completely abolished 
by  annexin V, provided that  annexin V binding  to  the  mem- 
branes  is maximal. Incomplete coverage with  annexin V  does 
not  inhibit  prothrombin conversion, and  this excludes  a direct 
interference of annexin V with either the assembly or the 
coagulation factors. This is illustrated  in  experiments  similar 
t o  those shown in Fig. 4, where preadsorption of 0.14-0.17 
pg/cm2 annexin V ( 7 0 4 0 %  of r,,,) to the PS/PC bilayer 
prior  to  prothrombinase assembly did  not affect the  prothrom- 
bin conversion rate  (data  not  shown).  These  data,  together 
with our observation that sufficient coagulation factors re- 
main  bound  to  the  membrane for  assembly of prothrombinase 
and for prothrombin  conversion, suggest that  the  complete, 
closed-packed coverage of the  surface  in itself interferes  with 
these processes (either  the assembly and/or  conversion).  For 
other proteins, however, this is not supported by available 
data.  Examples of poor inhibition  in  spite of complete surface 
coverage are:  50%  inhibition of prothrombinase  activity by 5 
p M  prothrombin  fragment 1 and  fragment 1-2 (33) and by 4 
p M  bone Gla protein (34) and less than 50% inhibition of 
tissue  factor-factor  VIIa  activity by 0.4 p~ apolipoprotein A- 
I, 0.4 p M  apolipoprotein A-11, 0.7 p M  C-reactive protein, or 
0.5 pM &-glycoprotein I (35). This poor inhibition by adsorp- 
tion of independent  protein molecules is seemingly in  contrast 
with  the recently  proposed concept  that  the lipid membrane 
accelerates coagulation reactions  primarily by  providing effi- 
cient  lateral  transport of the  reactants (1,  18, 36, 37). It  was 
calculated, however, that  due  to  the high lateral mobility and 
the high collisional efficiency of two-dimensional diffusion 
even very low surface  concentrations,  in  the  order of fmol. 
cm-', of the  reactants  are sufficient to  attain  the observed 
reaction  rates.  This  lateral mobility of isolated inhibitor mol- 
ecules  also causes  continuous  rearrangement of adsorbed mol- 
ecules on  the lipid  surface, and  this reshuffling will produce 
empty  spaces  on which, e.g. prothrombin may adsorb (32). 
In this framework it is attractive to speculate that the 
exceptionally complete  inhibition of prothrombinase by an- 
nexin V is  caused by the  formation of rigid clusters of annexin 
V on  the  membrane.  The  empty  spaces  in  the  clusters may be 
large enough to allow binding of coagulation factors, but 
adsorbed reactants, e.g. prothrombin, are unable to diffuse 
through  the  surrounding  cluster  and  no c llisional complexes 
will be  formed. The  present  study suggests that  this fencing 
mechanism  makes  annexin V an effective anticoagulant. 
Physiological Importance-Because plasma levels of an- 
nexin V are low (<0.2 nM) (39) a significant role of annexin 
V as a circulating anticoagulant is unlikely. On the other 
hand,  annexin V concentrations  in  cultured  endothelial cells 
are as high as 0.5% of the total amount of protein (38). 
Annexin V may, therefore,  protect  against  thrombosis  after 
endothelial cell damage. This  study shows that, for  a  limited 
procoagulant lipid surface  from  platelets, only  a small  amount 
of annexin V is  required for effective inhibition of prothrom- 
binase activity. 
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